CRO

Distributed Marketing Automation Leader SproutLoud Expands Leadership Team

Retrieved on: 
Friday, November 11, 2022

SproutLoud, an industry leader in distributed marketing automation software , is proud to announce the reorganization and expansion of its leadership team to support the companys accelerated growth.

Key Points: 
  • SproutLoud, an industry leader in distributed marketing automation software , is proud to announce the reorganization and expansion of its leadership team to support the companys accelerated growth.
  • Weve expanded our team to bring deeper expertise and capability, so SproutLoud continues to lead the enablement of brand-to-local teams.
  • Fidlon is SproutLouds Vice President of Marketing, overseeing the SproutLoud brand, marketing strategy, thought leadership, all marketing programs and the Martech stack.
  • SproutLouds advanced marketing automation technology simplifies every aspect of Distributed Marketing and delivers comprehensive analytics on tens of millions of touchpoints for major, category-leading brands.

Piano Software Names Mark Flaharty Chief Revenue Officer

Retrieved on: 
Friday, November 11, 2022

AMSTERDAM, Nov. 11, 2022 /PRNewswire/ -- Piano , a leading digital experience platform, today announced that Mark Flaharty has joined the organization as chief revenue officer (CRO).

Key Points: 
  • AMSTERDAM, Nov. 11, 2022 /PRNewswire/ -- Piano , a leading digital experience platform, today announced that Mark Flaharty has joined the organization as chief revenue officer (CRO).
  • "Mark has great wisdom about him, but also has a palpable enthusiasm for the Piano brand and the broad spectrum of opportunities ahead of us.
  • At Piano, Flaharty will hold responsibility for the revenue organization as the company continues to scale.
  • The data asset underlying Piano is massive simply put, nobody understands customers or their intent better," Flaharty said.

TaxConnex™ Proud to Exhibit at Thomson Reuters SYNERGY 2022 Conference

Retrieved on: 
Friday, November 11, 2022

ALPHARETTA, Ga., Nov. 11, 2022 /PRNewswire/ -- TaxConnex , a technology-enabled sales tax compliance outsourcing provider, shared that they are exhibiting at Thomson Reuters SYNERGY 2022 Conference for Corporate Professionals November 13-16.

Key Points: 
  • ALPHARETTA, Ga., Nov. 11, 2022 /PRNewswire/ -- TaxConnex , a technology-enabled sales tax compliance outsourcing provider, shared that they are exhibiting at Thomson Reuters SYNERGY 2022 Conference for Corporate Professionals November 13-16.
  • Thomson Reuters SYNERGY 2022 Conference for Corporate Professionals is in Washington, D.C. at the Gaylord National Harbor.
  • TaxConnex is proud to be exhibiting at the event where they can share their white-glove sales tax compliance offerings with the Thomson Reuters audience.
  • If you will be attending SYNERGY 2022 for Corporate Professionals November 13-16, be sure to visit TaxConnex at kiosk 221.

Sydney's Leading SEO Agency, Clickmatix, Reports a 46% Increase In Organic Leads Through SEO Efforts

Retrieved on: 
Wednesday, November 23, 2022

Clickmatix, Sydney's leading SEO agency, has data demonstrating 46% increase of Organic leads through SEO efforts as compared to the 2% from traditional outbound (cold calling) methods.

Key Points: 
  • The lead generation rates through organic methods are much higher as compared to the traditional outbound methods like cold calling outreach.
  • Businesses that invest in organic SEO can benefit from higher conversion rates, more brand recognition, and increased revenue.
  • As per the industry standard, implementing organic SEO efforts over years indicate that organic lead generation leads to 3x more conversions than any other marketing strategy.
  • Organic SEO may help improve connecting with prospects at the bottom of the marketing funnel.

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

Retrieved on: 
Thursday, November 10, 2022

HONG KONG, Nov 10, 2022 - (ACN Newswire) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.

Key Points: 
  • HONG KONG, Nov 10, 2022 - (ACN Newswire) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.
  • The company's service network has spread to 10 countries and regions worldwide, including the United States, Germany, Italy, Spain, Switzerland and Poland.
  • Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add.
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

EQS-News: Immunic to Participate in Investor and Scientific Conferences in November and December

Retrieved on: 
Friday, November 11, 2022

Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access.

Key Points: 
  • Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access.
  • An archived replay of the webcast will be available on the Events and Presentations section of Immunics website at: ir.imux.com/events-and-presentations .
  • Examples of such statements include, but are not limited to, statements relating to management's and employee's participation in investor and scientific conferences.
  • Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release.

Caidya Announces Appointment of Barbara Lopez Kunz to Board of Directors

Retrieved on: 
Wednesday, November 9, 2022

MORRISVILLE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Caidya, the multi-therapeutic clinical research organization (CRO) focused on delivery excellence and an elevated customer experience, announced today the appointment of Barbara Lopez Kunz to the Companys Board of Directors, effective November 1, 2022.

Key Points: 
  • MORRISVILLE, N.C., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Caidya, the multi-therapeutic clinical research organization (CRO) focused on delivery excellence and an elevated customer experience, announced today the appointment of Barbara Lopez Kunz to the Companys Board of Directors, effective November 1, 2022.
  • Kunz joins the Caidya Board currently serving as President and Chief Executive Officer of DIA (Drug Information Association), a global, member-driven organization mobilizing life sciences and healthcare professionals to improve health and well-being worldwide.
  • We are pleased to welcome Barbara to our Board, said Lingshi Tan, Ph.D., Chairman and Chief Executive Officer of Caidya.
  • It is an incredible privilege to join Caidyas Board of Directors at such an exciting time for the company, said Kunz.

Dr. Vince Clinical Research Announces Dosing of Ensysce’s PF614 Compound in Human Abuse Potential Trial

Retrieved on: 
Wednesday, November 9, 2022

I am excited to partner with DVCR on this critical program as we evaluate oral abuse potential of our PF614 product.

Key Points: 
  • I am excited to partner with DVCR on this critical program as we evaluate oral abuse potential of our PF614 product.
  • CNS-active new molecular entities (NMEs) are subject to an abuse potential evaluation and this evaluation may require a pivotal HAP study.
  • This particular study will examine the desirability of three doses of PF614 versus a current marketed equivalent and placebo in recreational drug users.
  • Dr. Vince Clinical Research (DVCR) is a world-class CRO (Contract Research Organization) with a custom-built, green-designed headquarters and research complex encompassing three buildings in Overland Park, KS.

Momentus Inc. Announces Retirement of Dawn Harms

Retrieved on: 
Thursday, November 10, 2022

Momentus Inc. (NASDAQ: MNTS) (Momentus or the "Company), a U.S. commercial space company that offers transportation and other in-space infrastructure services, today announced that Dawn Harms, Chief Revenue Officer, will retire effective Dec. 31, 2022.

Key Points: 
  • Momentus Inc. (NASDAQ: MNTS) (Momentus or the "Company), a U.S. commercial space company that offers transportation and other in-space infrastructure services, today announced that Dawn Harms, Chief Revenue Officer, will retire effective Dec. 31, 2022.
  • "We express our heartfelt thanks to Dawn for her leadership, resilience, and dedication to our company and our customers, said Momentus Chief Executive Officer John Rood.
  • On behalf of the entire team, we wish Dawn the best in her well-earned retirement.
  • Harms joined Momentus in 2019 as Chief Revenue Officer, leading the Companys commercial sales strategy.

Bluecore Appoints Chief Revenue Officer as It Scales Enterprise Adoption

Retrieved on: 
Thursday, November 10, 2022

This retail-specific approach is more important now than ever as retailers seek to generate predictable revenue in unpredictable market and economic circumstances.

Key Points: 
  • This retail-specific approach is more important now than ever as retailers seek to generate predictable revenue in unpredictable market and economic circumstances.
  • In 2019, Bluecore doubled down on its commitment to ecommerce revenue generation when it launched the industrys first shared-success pricing model.
  • Bluecore has already proven that its technology can transform people and processes to generate revenue.
  • In March 2022, the company announced Sherene Hilal as Chief Product Officer (CPO), Ryan Deutsch as Chief Customer Officer (CCO), and Arvind Krishnan as SVP of Engineering.